STRATA Skin Valuation

SSKN Stock  USD 2.20  0.05  2.22%   
Based on Macroaxis valuation methodology, the company appears to be undervalued. STRATA Skin Sciences has a current Real Value of $3.85 per share. The regular price of the company is $2.2. Our model measures the value of STRATA Skin Sciences from evaluating the company fundamentals such as return on equity of -1.51, and Shares Outstanding of 4.17 M as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
2.20
Please note that STRATA Skin's price fluctuation is relatively risky at this time. Calculation of the real value of STRATA Skin Sciences is based on 3 months time horizon. Increasing STRATA Skin's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since STRATA Skin is currently traded on the exchange, buyers and sellers on that exchange determine the market value of STRATA Stock. However, STRATA Skin's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.2 Real  3.85 Hype  2.18 Naive  2.07
The intrinsic value of STRATA Skin's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence STRATA Skin's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
3.85
Real Value
7.60
Upside
Estimating the potential upside or downside of STRATA Skin Sciences helps investors to forecast how STRATA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of STRATA Skin more accurately as focusing exclusively on STRATA Skin's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.192.362.52
Details
Hype
Prediction
LowEstimatedHigh
0.112.185.93
Details
Naive
Forecast
LowNext ValueHigh
0.042.075.82
Details

STRATA Skin Total Value Analysis

STRATA Skin Sciences is at this time forecasted to have valuation of 19.73 M with market capitalization of 9.18 M, debt of 16.44 M, and cash on hands of 10.04 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the STRATA Skin fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
19.73 M
9.18 M
16.44 M
10.04 M

STRATA Skin Investor Information

About 64.0% of the company shares are owned by institutional investors. The book value of STRATA Skin was at this time reported as 0.64. The company recorded a loss per share of 2.27. STRATA Skin Sciences last dividend was issued on the 7th of April 2017. The entity had 1:10 split on the 7th of June 2024. Based on the analysis of STRATA Skin's profitability, liquidity, and operating efficiency, STRATA Skin Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.

STRATA Skin Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. STRATA Skin has an asset utilization ratio of 92.82 percent. This suggests that the Company is making $0.93 for each dollar of assets. An increasing asset utilization means that STRATA Skin Sciences is more efficient with each dollar of assets it utilizes for everyday operations.

STRATA Skin Ownership Allocation

Over half of STRATA Skin's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions.

STRATA Skin Profitability Analysis

The company reported the previous year's revenue of 33.56 M. Net Loss for the year was (10.09 M) with profit before overhead, payroll, taxes, and interest of 19.65 M.

About STRATA Skin Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of STRATA Skin Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of STRATA Skin Sciences based exclusively on its fundamental and basic technical indicators. By analyzing STRATA Skin's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of STRATA Skin's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of STRATA Skin. We calculate exposure to STRATA Skin's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of STRATA Skin's related companies.
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. Strata Skin operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 115 people.

STRATA Skin Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding38.1 M
When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.